XS2406607098 · Corp · EUR

Teva Pharmaceutical Finance Nether 3.75% 2027/05

MID PRICE
117.56
par = 100
YIELD TO MAT.
3.89%
semi-annual
COUPON
3.750%
semi-annual · fixed
MATURITY
2027-05-09
bullet · 1.01y
OUTSTANDING
not disclosed
AS OF
2026-05-01
Fund disclosure

Sign up free to see prices on this bond

Free accounts get 40 bond price views per month — 4× the anonymous quota. Pro is unlimited.

Risk analytics

SEMI-ANNUAL · BULLET · PAR 100
Modified duration
0.97 y
1bp ↑ ≈ -0.010% P&L
Convexity
1.43
higher = more curvature
Years to maturity
1.01 y
YTM source
Ingested
Fund disclosure
G-spread
+122 bps
vs ECB AAA curve · 2026-04-29
Market signals · funds disclosing this bond
SignalCategoryExposureLast moveWeightAs of
iShares Global High Yield Corporate Bond
iShares
Global HY Corporate$120K▲ $3880.06%2026-05-01
Subscribe to reveal which signals are holding this bond.Subscribe →

Price history

Sherpa Signal

AS OF 2026-05-01

Institutional footprint · signal-level holdings

0/ 100
Interpretation. Thin coverage — below signal threshold
HOLDERS
1
unchanged in 7d
AGGREGATE EXPOSURE
$120K
USD across all
TOP CONCENTRATION
100.0%
largest holder
FLOW
unchanged in 7d

Sherpa Signal is derived from a panel of tracked institutional portfolios. Names of individual holders are not disclosed.

100K PAR NOTIONAL · MARKET VALUE
117,560 EUR
137,569 USD
FX SOURCE
ECB · CoinGecko
PRICE
117.56

RFQ routing · coming soon

Security details

VIA OPENFIGI
Canonical
TEVA 3 3/4 05/09/27
FIGI
BBG0136TNNQ8
ISIN
XS2406607098
Type
Corp
Issued
2021-11-09
Face value
100 EUR
Ticker
TEVA 3.75 05/09/27
Sec. type
GLOBAL
Seniority
Senior Unsecured

Issuer curve

TEVA · 10 PTS

Yield (%) plotted against years-to-maturity. This bond highlighted in amber.